Physiology and pathophysiology of human gut: intestine-on-chip

Patent metadata

Field	Value
Publication number	US-11566231-B2
Application number	US-202016825213-A
Country	US
Kind code	B2
Filing date	Mar 20, 2020
Priority date	Sep 21, 2017
Publication date	Jan 31, 2023
Grant date	Jan 31, 2023

Abstract

An in vitro microfluidic intestine on-chip is described herein that mimics the structure and at least one function of specific areas of the gastrointestinal system in vivo. In particular, a multicellular, layered, microfluidic intestinal cell culture, which is some embodiments is derived from patient's enteroids-derived cells, is described comprising L cells, allowing for interactions between L cells and gastrointestinal epithelial cells, endothelial cells and immune cells. This in vitro microfluidic system can be used for modeling inflammatory gastrointestinal autoimmune tissue, e.g., diabetes, obesity, intestinal insufficiency and other inflammatory gastrointestinal disorders. These multicellular-layered microfluidic intestine on-chips further allow for comparisons between types of gastrointestinal tissues, e.g., small intestinal duodenum, small intestinal jejunum, small intestinal ileum, large intestinal colon, etc., and between disease states of gastrointestinal tissue, i.e. healthy, pre-disease and diseased areas. Additionally, these microfluidic gut-on-chips allow identification of cells and cellular derived factors driving disease states and drug testing for reducing inflammation.

First claim

What is claimed is:

1. A method of culturing intestinal cells in vitro, comprising:
a) providing:
i) an intestinal enteroid or colonoid comprising intestinal epithelial cells;
ii) a population of endothelial cells;
iii) a microfluidic culture device comprising a membrane comprising-first surface and second surface; and

b) disrupting said intestinal enteroid or colonoid into enteroid or colonoid fragments;
c) seeding said enteroid or colonoid fragments on said first surface of said membrane so as to create seeded intestinal epithelial cells;
d) culturing said seeded intestinal epithelial cells for at least 18 hours and up to 4 days without seeded endothelial cells and without stretching of said membrane under conditions where culture fluid contacts said seeded cells at a flow rate;
e) seeding endothelial cells on said second surface of said membrane after step d) so as to create seeded endothelial cells; and
f) culturing said seeded epithelial cells and said seeded endothelial cells so as to create a cell barrier.

2. The method of claim 1 , wherein said barrier excludes a barrier test compound.

3. The method of claim 2 , wherein said barrier excludes a barrier test compound at Day 10 of culture of said epithelial cells.

4. The method of claim 2 , wherein said barrier excludes a barrier test compound at Day 11 of culture of said epithelial cells.

5. The method of claim 2 , wherein said barrier excludes a barrier test compound at Day 12 of culture of said epithelial cells.

6. The method of claim 2 , wherein said barrier excludes a barrier test compound at Day 13 of culture of said epithelial cells.

7. The method of claim 2 , wherein said barrier excludes a barrier test compound at Day 14 of culture of said epithelial cells.

8. The method of claim 2 , wherein said barrier test compound is selected from the group consisting of a dye, a dextran particle, 3 kDa particles, Cascade Blue, 450 Da particles, Lucifer Yellow, or a combination thereof.

9. The method of claim 1 , further comprising immunostaining said barrier and detecting said immunostaining by microscopic observation.

10. The method of claim 9 , wherein said immunostaining comprises immunostaining molecules selected from the group consisting of ZO-1 and vascular endothelial cadherin (VE-cadherin).

11. The method of claim 1 , wherein said barrier has low apparent permeability (P app ) values ranging from −0.5 to 1×10 6 centimeter/second.

12. The method of claim 1 , wherein said seeded epithelial cells differentiate into a monolayer comprising microvilli.

13. The method of claim 1 , wherein said seeded epithelial cells differentiate into two or more different differentiated intestinal cell types.

14. The method of claim 13 , wherein one of said two or more different differentiated intestinal cell types is selected from the group consisting of absorptive enterocytes, Paneth cells, and goblet cells.

15. The method of claim 13 , wherein one of said two or more different differentiated intestinal cell types is selected from the group consisting of Enterochromaffin cells and Tuft cells.

16. The method of claim 1 , further comprising a population of fibroblasts, wherein said fibroblast cells are seeded on said first surface before said intestinal epithelial cells so as to create a fibroblast cell layer.

17. The method of claim 16 , wherein said fibroblasts are selected from the group consisting of mitotically inactivated cells at the time of seeding and mitotically inactivated cells after seeding.

18. The method of claim 1 , wherein seeded epithelial cells undergo differentiation into differentiated intestinal cell types comprises L-cells.

19. The method of claim 18 , further comprising the step of g) detecting said L-cells.

20. The method of claim 19 , wherein said detecting shows 0.3%-1.9% of said L-cells in said differentiated intestinal cell types.

21. The method of claim 18 , further comprising exposing said L-cells to an agent.

22. The method of claim 1 , further comprising, after step e), using a mechanical force to stretch said membrane.

23. The method of claim 22 , wherein said membrane is stretched up to 10%.

24. The method of claim 22 , wherein said membrane is stretched in a cyclic manner.

25. The method of claim 1 , wherein said first surface comprises at least one extracellular matrix protein selected from the group consisting of Collagen IV and Matrigel.

26. The method of claim 1 , wherein said second surface comprises at least one extracellular matrix protein selected from the group consisting of Collagen IV and Fibronectin.

27. The method of claim 1 , wherein said surfaces are activated with a bifunctional crosslinker.

28. The method of claim 1 , wherein said intestinal enteroid or colonoid derive from primary intestinal tissue.

29. The method of claim 1 , wherein said intestinal epithelial cells are primary intestinal cells.

30. The method of claim 1 , wherein said intestinal epithelial cells are human cells.

31. The method of claim 1 , wherein said endothelial cells are human cells.

32. The method of claim 1 , wherein said intestinal enteroid or colonoid derive from an intestinal tissue biopsy.

33. The method of claim 32 , wherein said biopsy is removed from an adult patient.

34. The method of claim 32 , wherein said biopsy is removed from a pediatric patient.

35. The method of claim 32 , wherein said biopsy is from healthy intestine tissue.

36. The method of claim 32 , wherein said biopsy is from intestine tissue areas selected from the group consisting of a pre-disease area and a diseased area.

37. The method of claim 32 , wherein said biopsy is from inflammatory autoimmune tissue.

38. The method of claim 32 , wherein said biopsy is from intestine tissue selected from the group consisting of a small intestinal duodenum, small intestinal jejunum, small intestinal ileum, and large intestinal colon.

39. The method of claim 1 , further comprising, before or after step c), treating said intestinal cells with an inflammatory molecule.

40. The method of claim 1 , further comprising, before or after step e), treating said endothelial cells with an inflammatory molecule.

41. A method of culturing intestinal cells in vitro, comprising:
a) providing:
i) an intestinal enteroid or colonoid comprising intestinal epithelial cells;
ii) a population of endothelial cells;
iii) a microfluidic culture device comprising a membrane comprising-first surface and second surface; and

b) disrupting said intestinal enteroid or colonoid into enteroid or colonoid fragments;
c) seeding said enteroid or colonoid fragments on said first surface of said membrane so as to create seeded intestinal epithelial cells;
d) culturing said seeded intestinal epithelial cells for at least 18 hours and up to 4 days without seeded endothelial cells and without stretching of said membrane under conditions where culture fluid contacts said seeded cells at a flow rate;
e) seeding endothelial cells on said second surface of said membrane after step d) so as to create seeded endothelial cells;
f) stretching of said membrane after step e); and
g) culturing s

Assignees

• Emulate Inc

Inventors

• Apostolou Athanasia
• Varone Antonio
• Kasendra Magdalena
• Luc Raymond

Classifications

• C12M23/16

  Microfluidic devices; Capillary tubes (integrated microfluidic structures B01L3/5027; microreactors B01J19/0093) · CPC title

• C12M25/02

  Membranes; Filters (filters or filtration in general B01D24/00-B01D41/00) · CPC title

• G01N1/30

  Staining; Impregnating {; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis} · CPC title

• C12N5/0679 Primary

  Cells of the gastro-intestinal tract · CPC title

• C12M29/04

  Filters; Permeable or porous membranes or plates, e.g. dialysis · CPC title